Characterization of Muscarinic Receptor Subtypes in Canine Left Ventricular Membranes

References

• Ashkenazi A., Winslow J. W., Peralta E. G., Peterson G. L., Schimerlik M. I., Capon D. J., Ramachandran J. An M2 muscarinic receptor subtype coupled to both adenylyl cyclase and phosphoinositide turnover. Science 1987; 238: 672–675
   PubMed Web of Science ®Google Scholar
• Barlow R. B., Shepherd M. K. A further search for selective antagonists at M2-muscarinic receptors. Br. J. Pharmacol. 1986; 89: 837–843
   PubMedGoogle Scholar
• Bonner T. I. The molecular basis of muscarinic receptor diversity. Trends Neurosci. 1989; 12: 148–151
   PubMed Web of Science ®Google Scholar
• Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976; 72: 248–254
   PubMed Web of Science ®Google Scholar
• Brown J. H., Goldstein D. Analysis of cardiac muscarinic receptors recognized selectively by nonquaternary but not by quternary ligands. J. Pharmacol. Exp. Ther. 1986; 238: 580–586
   PubMedGoogle Scholar
• Buckley N. J., Bonner T. I., Buckley C. M., Brann M. R. Antagonist binding properties of five cloned muscarinic receptors expressed in CHO K1 cells. Mol. Pharmacol. 1989; 35: 469–476
   PubMed Web of Science ®Google Scholar
• Candell L. M., Yun S. H., Ly Ly Tran P., Ehlert F. J. Differential coupling of subtypes of the muscarinic receptor to adenylate cyclase and phosphoinositide hydrolysis in the longitudinal muscle of the rat ileum. Mol. Pharmacol. 1990; 38: 689–697
   Google Scholar
• Cheng Y.-C., Prusoff W. H. Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (IC50) of an enzymatic reaction. Biochem. Pharmacol. 1973; 22: 3099–3108
   PubMed Web of Science ®Google Scholar
• Clague R. V., Eglen R. M., Strachan A. C., Whiting R. L. Action of agonists and antagonists at muscarinic receptors present on ileum and atria in vitro. Br.J. Pharmacol. 1985; 86: 163–170
   Google Scholar
• Doods H. N., Mathy M. J., Davidesko D., Van Charldorp K. J., de Jonge A., van Zwieten P. A. Selectivey of muscarinic antagonists in radioligand and in vivo experiments for the putative M1 M2 and M3 receptors. J. Pharmacol. Exp. Ther. 1987; 242: 257–262
   PubMed Web of Science ®Google Scholar
• Galper J. B., Dziekan L. C., O'Hara D. S., Smith T. W. The biphasic response of muscarinic cholinergic receptors an cultured heart cells to agonists. J. Biol. Chem. 1982; 257: 10344–10356
   Google Scholar
• Giachetti A., Micheletti R., Montagna E. Cardioselective profile of AF-DX 116, a muscarinic M2 receptor antagonist. Life Sci. 1986; 38: 1663–1672
   PubMed Web of Science ®Google Scholar
• Giraldo E., Micheletti R., Montagna E., Giachetti A., Vigano M. A., Ladinsky H., Melchiorre C. Binding and functional characterization of the cardioselective muscarinic antagonist methoctramine. J. Pharmacol. Exp. Ther. 1988; 244: 1016–1020
   Google Scholar
• Hammer R., Berrie C. P., Birdsall N. J. M., Burgen A. S. V., Hulme E. C. Pirenzepine distinguishs between different subclasses of muscarinic receptors. Nature 1980; 283: 90–92
   PubMed Web of Science ®Google Scholar
• Hammer R., Giachetti A. Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterization. Life Sci. 1982; 31: 2991–2998
   PubMed Web of Science ®Google Scholar
• Huber F., Vulliemoz Y., Sun L. S., Robinson R. B., Bilezikian J. P. Characterization of the muscarinic receptor coupled to inositol phosphate formation in cultured myocytes from newborn rat hearts. FASEB J. 1991; 5: 2826a
   Google Scholar
• Hulme E. C., Birdsall N. J. M., Buckley N. J. Muscarinic receptor subtypes. Annu. Rev. Pharmacol. Toxicol. 1990; 30: 633–673
   PubMed Web of Science ®Google Scholar
• Kubo T., Haga M. K., Ichiyama A., Kangawa K., Kojima M., Matsuo H., Hirese T., Numa S. Cloning, sequencing and expression of complementary DNA encoding the muscarinic acetylcholine receptors. Nature (Lond) 1986; 323: 411–416
   PubMed Web of Science ®Google Scholar
• Ladinsky H., Giraldo E., Monferini E., Schiavi G. B., Vigano M. A., de Conti L., Micheletti R., Hammer R. Muscarinic receptor heterogeneity in smooth muscle: binding and functional studies with AF-DX 116. Trends Pharmacol. Sci. 1988; 44–48, Suppl
   Google Scholar
• Lee N. H., Ramkumar V., El-Fakahany E. E. Charge but not chemical class explains the selective binding of [3H]N-methylscopolamine to a subpopulation of [3H]quinuclidinyl benzilate binding sites in rat cerebral cortex homogenates. Eur. J. Pharmacol. 1986; 130: 153–155
   Google Scholar
• Melchiorre C., Angeli P., Lambrecht G., Mutschler E., Picchio M. T., Wess J. Antimuscarinic actions of methoctramine, a new cardioselective M2 muscarinic receptor antagonist, alone and in combination with atropine and gallamine. Eur. J. Pharmacol. 1987; 144: 117–124
   PubMedGoogle Scholar
• Micheletti R., Montagna E., Giachetti A. AF-DX 116, a cardioselective muscarinic antagonist. J. Pharmacol. Exp. Ther. 1987; 142: 628–634
   Google Scholar
• Mutschler E., Lambrecht G. Selective muscarinic agonists and antagonists in functional tests. Trends Pharmacol. Sci. 1984; 5(Suppl I)39–44
   Google Scholar
• Nathanson N. M. Binding of agonists and antagonists to muscarinic receptors on intact cultured heart cells. J. Neurochem. 1983; 41: 1545–1549
   Google Scholar
• Peralta E. G., Winslow J. W., Peterson J. L., Smith D. H., Ashkennnazi A., Ramachandran J., Schimerlik M. I., Capon D. J. Primary structure and biochemical properties of an M2 receptor. Science (Wash. DC) 1987; 236: 600–605
   PubMed Web of Science ®Google Scholar
• Peralta E. G., Ashkenazi A., Winslow J. W., Ramachandran J., Capon D. J. Differential regulation of PI hydrolysis and adenylyl cyclase by muscarinic receptor subtypes. Nature 1988; 334: 434–437
   PubMed Web of Science ®Google Scholar
• Shapiro R. A., Scherer N. M., Habecker B. A., Subers E. M., Nathanson N. M. Isolation, sequence and functional expression of the mouse M1 muscarinic acetylcholine receptor gene. J. Biol. Chem. 1988; 263: 18397–18403
   Google Scholar
• Siegel R. E., Fischbach G. D. Muscarinic receptors and responses in intact embryonic chick atrial and ventricular heart cells. Dev. Biol. 1984; 101: 346–356
   Google Scholar
• Subers E. M., Nathanson N. M. Muscarinic acetylcholine receptor function in chick heart cells cultured in serum-free medium. J. Mol. Cell Cardiol. 1988; 20: 131–140
   Google Scholar
• Watanabe A. M. Cardiac Therapy, M. R. Rosen, B. F. Hoffman. The Hague, Martinnus Nijhoff 1983; 95–144
   Google Scholar
• Watanabe A. M. Cellular mechanisms of muscarinic regulation of cardiac function. Nervous Control of Cardiac Function, W. Randall. Oxford University Press, New York 1984; 130–164
   Google Scholar
• Yang C. M., Farley J. M., Dwyer T. M. Biochemical characteristics of muscarinic cholinoreceptors in swine tracheal smooth muscle. J. Auton. Pharmacol. 1986; 6: 15–24
   Google Scholar
• Yang C. M. Characterization of muscarinic receptors in dog tracheal smooth muscle cells. J. Autonom. Pharmacol. 1991; 11: 51–61
   PubMedGoogle Scholar
• Zar J. H. Biostatistical analysis:Multiple regression and correlation. Prentice-Hall Inc., Englewood Cliffs, N. J. 1974; 252–280
   Google Scholar
• Maeda A., Kubo T., Mishina M., Numa S. Tissue distribution of mRNAs encoding muscarinic acetylcholine receptor subtypes. FEES Lett. 1988; 239: 339–342
   PubMed Web of Science ®Google Scholar
• Mizushima A., Uchida S., Zhou X.-M., Kagiya T., Yoshida H. Cardiac M2 receptors consist of two different types, both regulated by GTP. Eur. J. Pharmacol. 1987; 135: 403–409
   Google Scholar
• Lambrecht G., Feifel R., Forth B., Strohmann C., Tacke R., Mutschler E. p-Fluoro-hexahydro-sila-difenidol: the first M2b selective muscarinic antagonist. Eur. J. Pharmacol. 1988; 152: 193–194
   PubMedGoogle Scholar
• Zhou X.-M., Mizushima A., Uchida S., Watanabe Y., Yoshida H. The SH-H subgroup of cardiac M2 receptor (M2a) inhibits adenylate cyclase. Eur. J. Pharmacol. 1988; 154: 229–236
   Google Scholar
• Mizushima A., Uchida S., Zhou X.-M., Osugi T., Imaizumi T., Misaki N., Tatebayashi Y., Yoshida H. The H-L subgroup of guinea pig cardiac M2 receptors (M2B) regulates inositol phosphate formation. Eur. J. Pharmacol. 1989; 168: 375–380
   Google Scholar
• Ford A. P. D. W., Eglen R. M., Whiting R. L. Analysis of muscarinic cholinoceptors mediating phosphoinositide hydrolysis in guinea pig cardiac muscle. Eur. J. Pharmacol. Mol. Pharmacol. Sect. 1992; 225: 105–112
   Google Scholar
• Yang C. M., Chou S.-P., Sung T.-C. Muscarinic receptor subtypes coupled to generation of different second messengers in isolated tracheal smooth muscle cells. Br. J. Pharmacol. 1991; 104: 613–618
   Google Scholar